Loss of heterozygosity at D14S62 and metastatic potential of breast cancer

Journal of the National Cancer Institute

Volumn 91, Issue 16, 1999, Pages 1391-1397

  O'Connell, Peter ^a,b   Fischbach, Kathryn ^a   Hilsenbeck, Susan ^a   Mohsin, Syed K ^a   Fuqua, Suzanne A W ^a   Clark, Gary M ^a   Osborne, C Kent ^a   Allred, D Craig ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CHROMOSOME 14Q; CONTROLLED STUDY; GENE LOCUS; GENETIC MARKER; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; YEAST ARTIFICIAL CHROMOSOME;

EID: 0033581196     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.16.1391     Document Type: Article

References (31)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics [published erratum appears in CA Cancer J Clin 1997;47:68]. CA Cancer J Clin 1996;46:5-28.
2. American Cancer Society. Cancer facts and figures - 1997. New York (NY): American Cancer Society, Inc.; 1997.
3. SEER Cancer Statistics Review, 1973-1991: National Cancer Institute, NIH Publ No. 94-2789, 1994.
4. Nowell PC. The clonal evolution of tumor cell populations. Science 1976;194:23-8.
5. Klein G. The approaching era of the tumor suppressor genes. Science 1987;238:1539-45.
6. Weinberg RA. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res 1989;49:3713-21.
7. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991;64:327-36.
8. Sager R. Tumor suppressor genes: the puzzle and the promise. Science 1989;246:1406-12.
9. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985;230:1350-4.
10. Weber JL, May PE. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 1989;44:388-96.
11. Economou EP, Bergen AW, Warren AC, Antonarakis SE. The polydeoxyadenylate tract of Alu repetitive elements is polymorphic in the human genome. Proc Natl Acad Sci U S A 1990;87:2951-4.
12. Weissenbach J, Gyapay G, Dib C, Vignal A, Morissette J, Millasseau P, et al. A second generation linkage map of the human genome. Nature 1992;359:794-801.
13. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, et al. The 1993-94 Genethon human linkage map. Nat Genet 1994;7 (2 Spec No):246-339.
14. Hudson TJ, Stein LD, Gerety SS, Ma J, Castle AB, Silva J, et al. An STS-based map of the human genome. Science 1995;270:1945-54.
15. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R. Gallie BL, et al. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 1983;305:779-84.
16. Cropp CS, Lidereau R, Campbell G, Champene MH, Callahan R. Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified. Proc Natl Acad Sci U S A 1990;87:7737-41.
17. Devilee P, van den Broek M, Kuipers-Dijkshoorn N, Kolluri R, Meera-Khan P, Pearson PL, et al. At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma. Genomics 1989;5:554-60.
18. Sato T, Tanigami A, Yamakawa K, Akiyama F, Kazumi F, Satamoto G, et al. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res 1990;50:1784-9.
19. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266: 66-71.
20. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378:789-92.
21. Hennessy C, Henry JA, May FE, Westley BR, Angus B, Lennard TW. Expression of the antimetastastic gene nm23 in human breast cancer: an association with good prognosis. J Natl Cancer Inst 1991;83:281-5.
22. Lindblom A, Rotstein S, Skoog L, Nordenskjold M, Larsson C. Deletions of chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases. Cancer Res 1993;53:3707-11.
23. O'Connell P, Pekkel V, Fuqua SA, Osborne CK, Clark GM, Allred DC. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J Natl Cancer Inst 1998;90:697-703.
24. O'Connell P, Pekkel V, Fuqua SA, Osborne CK, Allred DC. Molecular genetic studies of early breast cancer evolution. Breast Cancer Res Treat 1994;32:5-12.
25. Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 1996; 274:2057-9.
26. Wright DK, Manos MM. Sample preparation from paraffin embedded tissues. In: Innes MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR protocols. San Diego (CA): Academic Press; 1990. p. 153-8.
27. Fasman KH, Letovsky SI, Cottingham RW, Kingsbury DT. Improvements to the GDB Human Genome Data Base. Nucleic Acids Res 1996;24:57-63.
28. Albertsen HM, Abderrahim H, Cann HM, Dausset J, le Paslier D, Cohen D. Construction and characterization of a human yeast artificial chromosome library containing seven haploid genome equivalents. Proc Natl Acad Sci U S A 1990;87:4256-60.
29. Nakamura Y, Lathrop M, O'Connell P, Leppert M, Kamboh MI, Lalouel JM, et al. Frequent recombination is observed in the distal end of the long arm of chromosome 14. Genomics 1989;4:76-81.
30. Chang WY, Cairns P, Schoenberg MP, Polascik TJ, Sidransky D. Novel suppressor loci on chromosome 14q in primary bladder cancer. Cancer Res 1995;55:3246-9.
31. Elston CW. Grading of invasive carcinoma of the breast. In: Page DL, Anderson TJ, editors. Diagnostic histopathology of the breast. New York (NY): Churchill Livingstone; 1987. p. 300-11.